Optimal Sequencing in Patients With RRMM Previously Treated With a BCMA-Targeted Therapy

Opinion
Video

Rafael Fonseca, MD, discusses the sequencing of CAR-T and bispecific antibodies in patients with relapsed/refractory multiple myeloma and tailoring treatment based on prior medical history for elderly and frail individuals.

Related Videos
Related Content